The annual socioeconomic cost of breast cancer in Cyprus is estimated at €180.9 million by 2024, according to the first published study examining the economic burden of the disease in the country, from the perspective of society.
According to the findings of the study, published in the scientific journal Expert Review of Pharmacoeconomics & Outcomes Research, 68.5% of the total cost relates to disease management, 11.7% to pharmaceutical costs, 1…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The annual socioeconomic cost of breast cancer in Cyprus is estimated at €180.9 million by 2024, according to the first published study examining the economic burden of the disease in the country, from the perspective of society.
According to the findings of the study, published in the scientific journal Expert Review of Pharmacoeconomics & Outcomes Research, 68.5% of the total cost relates to disease management, 11.7% to pharmaceutical costs, 1…